vs
Side-by-side financial comparison of Clarus Corp (CLAR) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
Clarus Corp is the larger business by last-quarter revenue ($65.4M vs $39.6M, roughly 1.7× SBC Medical Group Holdings Inc). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs -47.8%, a 83.7% gap on every dollar of revenue. On growth, Clarus Corp posted the faster year-over-year revenue change (-8.4% vs -10.9%). SBC Medical Group Holdings Inc produced more free cash flow last quarter ($51.2M vs $11.6M). Over the past eight quarters, Clarus Corp's revenue compounded faster (-2.9% CAGR vs -15.0%).
Clarus Corp is a global designer, manufacturer, and distributor of high-performance outdoor recreation, climbing, camping, and lifestyle products. It manages a portfolio of leading consumer brands, serving outdoor enthusiasts, professional athletes, and retail partners across North America, Europe, and the Asia-Pacific region, with a focus on innovative, durable gear for active lifestyles.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
CLAR vs SBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $65.4M | $39.6M |
| Net Profit | $-31.3M | $14.2M |
| Gross Margin | 27.7% | 73.1% |
| Operating Margin | -59.6% | 32.5% |
| Net Margin | -47.8% | 35.9% |
| Revenue YoY | -8.4% | -10.9% |
| Net Profit YoY | 52.3% | 117.2% |
| EPS (diluted) | $-0.81 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $65.4M | $39.6M | ||
| Q3 25 | $69.3M | $43.4M | ||
| Q2 25 | $55.2M | $43.4M | ||
| Q1 25 | $60.4M | $47.3M | ||
| Q4 24 | $71.4M | $44.4M | ||
| Q3 24 | $67.1M | $53.1M | ||
| Q2 24 | $56.5M | $53.1M | ||
| Q1 24 | $69.3M | $54.8M |
| Q4 25 | $-31.3M | $14.2M | ||
| Q3 25 | $-1.6M | $12.8M | ||
| Q2 25 | $-8.4M | $2.5M | ||
| Q1 25 | $-5.2M | $21.5M | ||
| Q4 24 | $-65.5M | $6.5M | ||
| Q3 24 | $-3.2M | $2.8M | ||
| Q2 24 | $-5.5M | $18.5M | ||
| Q1 24 | $21.9M | $18.8M |
| Q4 25 | 27.7% | 73.1% | ||
| Q3 25 | 35.1% | 70.6% | ||
| Q2 25 | 35.6% | 69.2% | ||
| Q1 25 | 34.4% | 79.7% | ||
| Q4 24 | 33.4% | 76.3% | ||
| Q3 24 | 35.0% | 81.5% | ||
| Q2 24 | 36.1% | 74.2% | ||
| Q1 24 | 35.9% | 72.1% |
| Q4 25 | -59.6% | 32.5% | ||
| Q3 25 | -4.4% | 36.6% | ||
| Q2 25 | -19.7% | 33.6% | ||
| Q1 25 | -11.2% | 51.1% | ||
| Q4 24 | -70.2% | 10.6% | ||
| Q3 24 | -8.0% | 26.1% | ||
| Q2 24 | -14.4% | 51.4% | ||
| Q1 24 | -9.8% | 44.6% |
| Q4 25 | -47.8% | 35.9% | ||
| Q3 25 | -2.3% | 29.6% | ||
| Q2 25 | -15.3% | 5.7% | ||
| Q1 25 | -8.7% | 45.4% | ||
| Q4 24 | -91.8% | 14.7% | ||
| Q3 24 | -4.7% | 5.3% | ||
| Q2 24 | -9.7% | 34.8% | ||
| Q1 24 | 31.6% | 34.2% |
| Q4 25 | $-0.81 | $0.15 | ||
| Q3 25 | $-0.04 | $0.12 | ||
| Q2 25 | $-0.22 | $0.02 | ||
| Q1 25 | $-0.14 | $0.21 | ||
| Q4 24 | $-1.72 | $0.05 | ||
| Q3 24 | $-0.08 | $0.03 | ||
| Q2 24 | $-0.14 | $0.20 | ||
| Q1 24 | $0.57 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $36.7M | $164.1M |
| Total DebtLower is stronger | $0 | $42.8M |
| Stockholders' EquityBook value | $196.4M | $248.3M |
| Total Assets | $249.0M | $380.4M |
| Debt / EquityLower = less leverage | 0.00× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $36.7M | $164.1M | ||
| Q3 25 | $29.5M | $127.4M | ||
| Q2 25 | $28.5M | $152.7M | ||
| Q1 25 | $41.3M | $132.1M | ||
| Q4 24 | $45.4M | $125.0M | ||
| Q3 24 | $36.4M | $137.4M | ||
| Q2 24 | $46.2M | — | ||
| Q1 24 | $47.5M | — |
| Q4 25 | $0 | $42.8M | ||
| Q3 25 | $2.0M | $21.1M | ||
| Q2 25 | $1.9M | $7.1M | ||
| Q1 25 | $1.9M | $6.9M | ||
| Q4 24 | $1.9M | $6.6M | ||
| Q3 24 | — | $823.2K | ||
| Q2 24 | — | — | ||
| Q1 24 | $37.0K | — |
| Q4 25 | $196.4M | $248.3M | ||
| Q3 25 | $225.8M | $248.0M | ||
| Q2 25 | $225.1M | $244.6M | ||
| Q1 25 | $229.3M | $226.4M | ||
| Q4 24 | $233.1M | $195.1M | ||
| Q3 24 | $308.5M | $205.0M | ||
| Q2 24 | $307.3M | $8.8M | ||
| Q1 24 | $310.4M | $9.0M |
| Q4 25 | $249.0M | $380.4M | ||
| Q3 25 | $283.1M | $321.4M | ||
| Q2 25 | $286.5M | $315.3M | ||
| Q1 25 | $292.8M | $284.6M | ||
| Q4 24 | $294.1M | $266.1M | ||
| Q3 24 | $375.3M | $296.5M | ||
| Q2 24 | $369.4M | $19.5M | ||
| Q1 24 | $377.0M | $19.8M |
| Q4 25 | 0.00× | 0.17× | ||
| Q3 25 | 0.01× | 0.09× | ||
| Q2 25 | 0.01× | 0.03× | ||
| Q1 25 | 0.01× | 0.03× | ||
| Q4 24 | 0.01× | 0.03× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.00× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $12.5M | $52.0M |
| Free Cash FlowOCF − Capex | $11.6M | $51.2M |
| FCF MarginFCF / Revenue | 17.7% | 129.3% |
| Capex IntensityCapex / Revenue | 1.4% | 2.0% |
| Cash ConversionOCF / Net Profit | — | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | $-9.9M | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $12.5M | $52.0M | ||
| Q3 25 | $-5.7M | $-20.9M | ||
| Q2 25 | $-9.4M | $-8.3M | ||
| Q1 25 | $-2.1M | $1.9M | ||
| Q4 24 | $16.6M | $-7.3M | ||
| Q3 24 | $-8.3M | $5.0M | ||
| Q2 24 | $834.0K | $19.2M | ||
| Q1 24 | $-16.4M | $3.7M |
| Q4 25 | $11.6M | $51.2M | ||
| Q3 25 | $-7.0M | $-20.9M | ||
| Q2 25 | $-11.3M | $-8.6M | ||
| Q1 25 | $-3.3M | $1.7M | ||
| Q4 24 | $14.4M | $-7.9M | ||
| Q3 24 | $-9.4M | $4.6M | ||
| Q2 24 | $-744.0K | $18.3M | ||
| Q1 24 | $-18.3M | $3.0M |
| Q4 25 | 17.7% | 129.3% | ||
| Q3 25 | -10.0% | -48.3% | ||
| Q2 25 | -20.4% | -19.9% | ||
| Q1 25 | -5.4% | 3.5% | ||
| Q4 24 | 20.1% | -17.8% | ||
| Q3 24 | -14.0% | 8.7% | ||
| Q2 24 | -1.3% | 34.5% | ||
| Q1 24 | -26.3% | 5.4% |
| Q4 25 | 1.4% | 2.0% | ||
| Q3 25 | 1.8% | 0.1% | ||
| Q2 25 | 3.4% | 0.7% | ||
| Q1 25 | 2.0% | 0.5% | ||
| Q4 24 | 3.1% | 1.3% | ||
| Q3 24 | 1.6% | 0.8% | ||
| Q2 24 | 2.8% | 1.6% | ||
| Q1 24 | 2.7% | 1.3% |
| Q4 25 | — | 3.66× | ||
| Q3 25 | — | -1.63× | ||
| Q2 25 | — | -3.39× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | — | -1.12× | ||
| Q3 24 | — | 1.77× | ||
| Q2 24 | — | 1.04× | ||
| Q1 24 | -0.75× | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CLAR
| Other | $37.1M | 57% |
| Outdoor Segment | $25.3M | 39% |
| Adventure Segment | $3.0M | 5% |
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
